{"id": "1354948114428252183", "creation": 1611879778.0, "user_id": "55186601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 2, "reply_count": 0, "like_count": 4, "quote_count": 0}}, "text": "#NSTworld US biotech firm #Novavax said its two-shot #Covid19 #vaccine showed an overall efficacy of 89.3 per cent in a major #Phase3 clinical trial in Britain, and remained highly effective against a variant first identified there.\n\nhttps://t.co/3dSWcgsxh3\n\n#coronavirus", "first_save": 1634559108.199414, "hashtags": ["#NSTWORLD", "#NOVAVAX", "#COVID19", "#VACCINE", "#PHASE3", "#CORONAVIRUS"]}